Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: KRAS MUTATION, . Treffer: 30

2020

Fakler, F; Aykutlu, U; Brcic, L; Eidenhammer, S; Thueringer, A; Kashofer, K; Kulka, J; Timens, W; Popper, H Atypical goblet cell hyperplasia occurs in CPAM 1, 2, and 3, and is a probable precursor lesion for childhood adenocarcinoma.
Virchows Arch. 2020; 476(6):843-854
Web of Science PubMed FullText FullText_MUG

 

Timar, J; Kashofer, K Molecular epidemiology and diagnostics of KRAS mutations in human cancer
CANCER METAST REV. 2020;
Web of Science PubMed FullText FullText_MUG

 

Unseld, M; Belic, J; Pierer, K; Zhou, Q; Moser, T; Bauer, R; Piringer, G; Gerger, A; Siebenhüner, A; Speicher, M; Heitzer, E; Prager, GW A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy (RELAIS) translational biomarker phase II pilot study.
Int J Cancer. 2020;
PubMed FullText FullText_MUG

 

2019

Arriga, R; Caratelli, S; Lanzilli, G; Ottaviani, A; Cenciarelli, C; Sconocchia, T; Spagnoli, GC; Iezzi, G; Roselli, M; Lauro, D; Coppola, A; Dotti, G; Ferrone, S; Sconocchia, G CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximab.
INT J CANCER. 2019; 14(8):
Web of Science PubMed FullText FullText_MUG

 

Liebs, S; Keilholz, U; Kehler, I; Schweiger, C; Haybäck, J; Nonnenmacher, A Detection of mutations in circulating cell-free DNA in relation to disease stage in colorectal cancer.
Cancer Med. 2019; 8(8):3761-3769 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Margonis, GA; Amini, N; Andreatos, N; Sasaki, K; McVey, J; Mirza, MB; Warner, S; Buettner, S; Barbon, C; Wang, J; Pulvirenti, A; Angelou, A; Kamphues, C; Antoniou, E; Pikoulis, E; Pawlik, TM; Kaczirek, K; Poultsides, G; Wagner, D; Endo, I; Imai, K; Aucejo, F; Kreis, ME; Wolfgang, CL; Weiss, MJ KRAS mutational status impacts pathologic response to pre-hepatectomy chemotherapy: a study from the International Genetic Consortium for Liver Metastases.
HPB (Oxford). 2019; 21(11):1527-1534
Web of Science PubMed FullText FullText_MUG

 

Margonis, GA; Amini, N; Buettner, S; Kim, Y; Wang, J; Andreatos, N; Wagner, D; Sasaki, K; Beer, A; Kamphues, C; Morioka, D; Løes, IM; Imai, K; He, J; Pawlik, TM; Kaczirek, K; Poultsides, G; Lønning, PE; Burkhart, R; Endo, I; Baba, H; Mischinger, HJ; Aucejo, FN; Kreis, ME; Wolfgang, CL; Weiss, MJ The Prognostic Impact of Primary Tumor Site Differs According to the KRAS Mutational Status: A Study By the International Genetic Consortium for Colorectal Liver Metastasis.
Ann Surg. 2019;
PubMed FullText FullText_MUG

 

Margonis, GA; Buettner, S; Andreatos, N; Wagner, D; Sasaki, K; Barbon, C; Beer, A; Kamphues, C; Løes, IM; He, J; Pawlik, TM; Kaczirek, K; Poultsides, G; Lønning, PE; Cameron, JL; Mischinger, HJ; Aucejo, FN; Kreis, ME; Wolfgang, CL; Weiss, MJ Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases: A Multi-institutional, International Analysis of 1099 Patients.
ANN SURG. 2019; 269(6): 1129-1137.
Web of Science PubMed FullText FullText_MUG

 

2018

Margonis, GA; Buettner, S; Andreatos, N; Kim, Y; Wagner, D; Sasaki, K; Beer, A; Schwarz, C; Løes, IM; Smolle, M; Kamphues, C; He, J; Pawlik, TM; Kaczirek, K; Poultsides, G; Lønning, PE; Cameron, JL; Burkhart, RA; Gerger, A; Aucejo, FN; Kreis, ME; Wolfgang, CL; Weiss, MJ Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
JAMA Surg. 2018; 153(7): e180996-e180996. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Margonis, GA; Buettner, S; Andreatos, N; Wagner, D; Sasaki, K; Barbon, C; Beer, A; Kamphues, C; Løes, IM; He, J; Pawlik, TM; Kaczirek, K; Poultsides, G; Lønning, PE; Cameron, JL; Mischinger, HJ; Aucejo, FN; Kreis, ME; Wolfgang, CL; Weiss, MJ Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases: A Multi-institutional, International Analysis of 1099 Patients.
Ann Surg. 2018;
PubMed FullText FullText_MUG

 

Zaric, B; Brcic, L; Buder, A; Brandstetter, A; Buresch, JO; Traint, S; Kovacevic, T; Stojsic, V; Perin, B; Pirker, R; Filipits, M PD-1 and PD-L1 Protein Expression Predict Survival in Completely Resected Lung Adenocarcinoma.
Clin Lung Cancer. 2018; 19(6):e957-e963-e957-e963
Web of Science PubMed FullText FullText_MUG

 

2016

Brcic, L; Jakopovic, M; Misic, M; Seiwerth, F; Kern, I; Smojver-Jezek, S; Quehenberger, F; Samarzija, M; Seiwerth, S Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia.
Diagn Pathol. 2016; 11(1):90-90 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Geles, A; Gruber-Moesenbacher, U; Quehenberger, F; Manzl, C; Al Effah, M; Grygar, E; Juettner-Smolle, F; Popper, HH Pulmonary mucinous adenocarcinomas: architectural patterns in correlation with genetic changes, prognosis and survival.
Virchows Arch. 2015; 467(6):675-686
Web of Science PubMed FullText FullText_MUG

 

Grabner, B; Schramek, D; Mueller, KM; Moll, HP; Svinka, J; Hoffmann, T; Bauer, E; Blaas, L; Hruschka, N; Zboray, K; Stiedl, P; Nivarthi, H; Bogner, E; Gruber, W; Mohr, T; Zwick, RH; Kenner, L; Poli, V; Aberger, F; Stoiber, D; Egger, G; Esterbauer, H; Zuber, J; Moriggl, R; Eferl, R; Győrffy, B; Penninger, JM; Popper, H; Casanova, E Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis.
Nat Commun. 2015; 6(4):6285-6285 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Langner, C Serrated and non-serrated precursor lesions of colorectal cancer.
Dig Dis. 2015; 33(1):28-37
Web of Science PubMed FullText FullText_MUG

 

Zopf, A; Raim, R; Danzer, M; Niklas, N; Spilka, R; Pröll, J; Gabriel, C; Nechansky, A; Roucka, M Introduction of the hybcell-based compact sequencing technology and comparison to state-of-the-art methodologies for KRAS mutation detection.
Biotechniques. 2015; 58(3):126-134 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Pichler, M; Winter, E; Ress, AL; Bauernhofer, T; Gerger, A; Kiesslich, T; Lax, S; Samonigg, H; Hoefler, G miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor.
J Clin Pathol. 2014; 67(3):198-203
Web of Science PubMed FullText FullText_MUG

 

Rau, TT; Agaimy, A; Gehoff, A; Geppert, C; Jung, K; Knobloch, K; Langner, C; Lugli, A; Groenbus-Lurkin, I; Nagtegaal, ID; Rüschoff, J; Saegert, X; Sarbia, M; Schneider-Stock, R; Vieth, M; Zwarthoff, EC; Hartmann, A Defined morphological criteria allow reliable diagnosis of colorectal serrated polyps and predict polyp genetics.
Virchows Arch. 2014; 464(6):663-672
Web of Science PubMed FullText FullText_MUG

 

2013

Dijkstra, JR; Heideman, DA; Meijer, GA; Boers, JE; 't Hart, NA; Diebold, J; Hirschmann, A; Hoefler, G; Winter, G; Miltenberger-Miltenyi, G; Pereira, SV; Richman, SD; Quirke, P; Rouleau, EL; Guinebretiere, JM; Tejpar, S; Biesmans, B; van Krieken, JH KRAS mutation analysis on low percentage of colon cancer cells: the importance of quality assurance.
Virchows Arch. 2013; 462(1):39-46
Web of Science PubMed FullText FullText_MUG

 

Moldvay, J; Barbai, T; Bogos, K; Piurko, V; Fillinger, J; Popper, HH; Tímár, J EGFR autophosphorylation but not protein score correlates with histologic and molecular subtypes in lung adenocarcinoma.
Diagn Mol Pathol. 2013; 22(4):204-209
Web of Science PubMed FullText FullText_MUG

 

2012

Dijkstra, JR; Opdam, FJ; Boonyaratanakornkit, J; Schönbrunner, ER; Shahbazian, M; Edsjö, A; Hoefler, G; Jung, A; Kotsinas, A; Gorgoulis, VG; Lpez-Ros, F; de Stricker, K; Rouleau, E; Biesmans, B; van Krieken, JH Implementation of formalin-fixed, paraffin-embedded cell line pellets as high-quality process controls in quality assessment programs for KRAS mutation analysis.
J Mol Diagn. 2012; 14(3):187-191 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Betge, J; Pollheimer, MJ; Schlemmer, A; Hoefler, G; Langner, C Gastric cancer and concomitant renal cancer: a systematic immunohistochemical and molecular analysis.
Oncol Rep. 2011; 26(3):567-575 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kriegshäuser, G; Auner, V; Schuster, E; Holzer, B; Oberkanins, C; Horvat, R; Speiser, P; Zeillinger, R KRAS mutation analysis in genomic DNA isolated from formalin-fixed paraffin-embedded ovarian tissue: evaluation of a strip-based reverse-hybridisation assay.
J Clin Pathol. 2011; 64(3): 252-256.
Web of Science PubMed FullText FullText_MUG

 

Kriegshäuser, G; Fabjani, G; Ziegler, B; Zöchbauer-Müller, S; End, A; Zeillinger, R Biochip-based detection of KRAS mutation in non-small cell lung cancer.
Int J Mol Sci. 2011; 12(12): 8530-8538. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2010

Kriegshäuser, G; Auner, V; Zeillinger, R New and potential clinical applications of KRAS as a cancer biomarker.
Expert Opin Med Diagn. 2010; 4(5):383-395
PubMed FullText FullText_MUG

 

Voortman, J; Goto, A; Mendiboure, J; Sohn, JJ; Schetter, AJ; Saito, M; Dunant, A; Pham, TC; Petrini, I; Lee, A; Khan, MA; Hainaut, P; Pignon, JP; Brambilla, E; Popper, HH; Filipits, M; Harris, CC; Giaccone, G MicroRNA Expression and Clinical Outcomes in Patients Treated with Adjuvant Chemotherapy after Complete Resection of Non-Small Cell Lung Carcinoma.
Cancer Res. 2010; 70(21): 8288-8298. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

2009

Auner, V; Kriegshäuser, G; Tong, D; Horvat, R; Reinthaller, A; Mustea, A; Zeillinger, R KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay.
BMC Cancer. 2009; 9(1): 111-111. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Ausch, C; Buxhofer-Ausch, V; Oberkanins, C; Holzer, B; Minai-Pour, M; Jahn, S; Dandachi, N; Zeillinger, R; Kriegshäuser, G Sensitive detection of KRAS mutations in archived formalin-fixed paraffin-embedded tissue using mutant-enriched PCR and reverse-hybridization.
J Mol Diagn. 2009; 11(6):508-513 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2008

Schulz, AL; Albrecht, B; Arici, C; van der Burgt, I; Buske, A; Gillessen-Kaesbach, G; Heller, R; Horn, D; Hübner, CA; Korenke, GC; König, R; Kress, W; Krüger, G; Meinecke, P; Mücke, J; Plecko, B; Rossier, E; Schinzel, A; Schulze, A; Seemanova, E; Seidel, H; Spranger, S; Tuysuz, B; Uhrig, S; Wieczorek, D; Kutsche, K; Zenker, M Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome.
Clin Genet. 2008; 73(1):62-70
Web of Science PubMed FullText FullText_MUG

 

van Krieken, JH; Jung, A; Kirchner, T; Carneiro, F; Seruca, R; Bosman, FT; Quirke, P; Fléjou, JF; Plato Hansen, T; de Hertogh, G; Jares, P; Langner, C; Hoefler, G; Ligtenberg, M; Tiniakos, D; Tejpar, S; Bevilacqua, G; Ensari, A KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program.
Virchows Arch. 2008; 453(5): 417-431. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

© Med Uni Graz Impressum